KRISTINA ROWE: Open Payments
NPI 1528236262 · IRONTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$69,879 in 126 payments from 8 companies in 2025. Trend: 2023 $51,848 · 2024 $45,237 · 2025 $69,879
Speaker / faculty: $52,800Travel & lodging: $8,951Consulting: $6,000Food & beverage: $2,128
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 57 | $46,112 |
| ABBVIE INC. | 57 | $23,451 |
| Vanda Pharmaceuticals Inc. | 5 | $186 |
| Lundbeck LLC | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $21 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: INGREZZA, VRAYLAR, HETLIOZ, FANAPT, REXULTI, ABILIFY ASIMTUFII, ARISTADA, CAPLYTA.
Industry payments across OH — which companies pay providers there.
